Vesalius Therapeutics lands $75m - venturecapitaljournal.com

Cambridge, Mass., March 2, 2022 – Flagship Pioneering today unveiled Vesalius Therapeutics, a company focused on redefining the understanding and treatment of the diseases that drive …

CouponFollow Extension

$75
OFF

Vesalius Therapeutics Lands $75m - Venturecapitaljournal.com

2 weeks from now

Cambridge, Mass., March 2, 2022 – Flagship Pioneering today unveiled Vesalius Therapeutics, a company focused on redefining the understanding and treatment of the diseases that drive …

venturecapitaljournal.com

$75
OFF

Vesalius Therapeutics Raises $75M - VC News Daily

2 weeks from now

Mar 2, 2022 · Flagship Pioneering today unveiled Vesalius Therapeutics, a company focused on redefining the understanding and treatment of the diseases that drive ninety percent of human …

vcnewsdaily.com

$75
OFF

Flagship Unveils Vesalius With $75M To Bankroll Ambitious Target …

2 weeks from now

Mar 9, 2022 · Now, 30-plus years later, the two have come together to co-found Flagship’s Vesalius Therapeutics in a $75 million attempt to solve the problem. The Cambridge, …

biotech-insider.com

90%
OFF

Vesalius, Rondo Debut To Redefine Treatment Paradigms

2 weeks from now

Mar 2, 2022 · A new month brings a fresh new crop of innovators to the biopharma industry. Flagship Pioneering has launched a new company with the goal of redefining how 90% of …

biospace.com

$75
OFF

Vesalius Therapeutics - Raised $75M Funding From 1 Investor

2 weeks from now

Jan 28, 2025 · Vesalius Therapeutics has raised a total funding of $75M over 1 round from 1 investor. Investor includes Flagship Pioneering. Their latest funding round was of $75M on …

tracxn.com

$75
OFF

Flagship Unveils Vesalius With $75M To Bankroll Ambitious Target …

2 weeks from now

Mar 9, 2022 · When Christopher Austin, M.D., and Doug Cole, M.D., were co-residents at Massachusetts General Hospital in the late ’80s, they realized the diagnoses and treatments …

biotech-today.com

$80
OFF

GSK Pays Flagship Biotech $80M For Preclinical Neuro Pact

2 weeks from now

Nov 12, 2024 · GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that includes a preclinical small molecule initially …

fiercebiotech.com

$75
OFF

Venture Capital News: Vesalius Therapeutics Raises $75M

2 weeks from now

Flagship Pioneering today unveiled Vesalius Therapeutics, a company focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness. …

vcnewsdaily.com